eMedevents
  • 151,232+ Medical Conferences
  • 284 Specialties
  • 11,127 Organizers
  • 155,429 Speakers
  • 159 Countries
  • 4,741 Cities
50,411+
CME Conference Registrations Sold
Home  >  Speakers  >  Charles Erlichman
Charles Erlichman

Charles Erlichman

    MD
Professor | Rochester, Minnesota    United States of America
Oncology
Multidisciplinary Approach To Laboratory Studies Oncology,...More
Spoken at 1 event

Biography :

Dr. C. Erlichman, Professor of Oncology Mayo Clinic, led the phase 1 program at Mayo Clinic for >20 years and created a multicenter, multinational phase 2 clinical trials consortium. He performed one of the first trials that demonstrated the combination of 5FU and folinic acid was effective in patients with metastatic colorectal cancer and as an adjuvant in colon cancer.

He was principle investigator on the first in human trial of granisetron that demonstrated its anti-emetic potential in platinum based chemotherapy. Throughout his career he has translated preclinical discoveries into early clinical therapeutic clinical trials as demonstrated by the combination of bevacizumab and temsirolimus was highly promising in PNETs in a phase 2 trial.

**********************
** ************
This section has yet to be updated by the speaker.
For speaker's contact information - Contact us

Specialties

Oncology

Interested Topics

Multidisciplinary approach to laboratory studies of the pharmacology of drugs used in cancer therapy to the design and execution of clinical trials for cancer treatment, Oncology, Cancer therapy, Clinical Research, Colorectal cancer, Colon cancer

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.

Languages

English

Conference Session Materials

The conference session material has yet to be added by the speaker.
Close

Send Message